| 英文名称 | 中文名称 | CAS | MF |
|
2-(3,4-bis(allyloxy)phenyl)acetic acid
|
1642165-89-6
|
1642165-89-6
|
C14H16O4
|
|
Vortioxetine Impurity 32
|
沃替西汀杂质32
|
1642185-28-1
|
C14H13BrS
|
|
2-(3-Chloro-4-fluorophenyl)-N-(1-methylethyl)-6-[3-(4-morpholinyl)propoxy]-4-oxo-pyrido[2,3-d]pyrimidine-3(4H)-acetamide hydrochloride
|
2-(3-Chloro-4-fluorophenyl)-N-(1-methylethyl)-6-[3-(4-morpholinyl)propoxy]-4-oxo-pyrido[2,3-d]pyrimidine-3(4H)-acetamide hydrochloride
|
1642187-96-9
|
C25H30Cl2FN5O4
|
|
Mavacamten
|
玛伐凯泰
|
1642288-47-8
|
C15H19N3O2
|
|
SRN-927)
|
1642297-01-5
|
1642297-01-5
|
C28H28FNO4
|
|
GDC-0927 R-form
|
(R)-2-(4-(2-(3-(氟甲基)氮杂环丁烷-1-基)乙氧基)苯基)-3-(3-羟基苯基)-4-甲基-2H-苯并吡喃-6-醇
|
1642297-53-7
|
C28H28FNO4
|
|
3-(fluoromethyl)azetidine hydrochloride
|
3-(氟甲基)氮杂环丁烷盐酸盐
|
1642298-59-6
|
C4H9ClFN
|
|
KPT-8602
|
CS-2388
|
1642300-52-4
|
C17H10F6N6O
|
|
KPT-8602 (Z-isomer)
|
1642300-78-4
|
1642300-78-4
|
C17H10F6N6O
|
|
(S)-1-(benzo[d][1,3]dioxol-5-yl)ethanamine hydrochloride(WXC09203S1)
|
(S)-1-(苯并[D][1,3]二噁戊环-5-基)乙胺盐酸
|
1642301-09-4
|
C9H12ClNO2
|
|
(3S)-2-(4-bromo-2-fluorobenzyl)-3-methyl-6-phenyl-1,2-thiazinane 1,1-dioxide(WXC04782)
|
(3S)-2-(4-溴-2-氟苯甲基)-3-甲基-6-苯基-1,2-噻嗪烷 1,1-二氧化
|
1642303-04-5
|
C18H19BrFNO2S
|
|
PDE1-IN-1 (phosphate)
|
1642303-38-5
|
1642303-38-5
|
C29H29FN7O5P
|
|
Otophylloside T
|
Otophylloside T
|
1642306-14-6
|
C48H70O18
|
|
5,5-difluoro-1,3,7,9-tetramethyl-10-(trifluoromethyl)-9a,10-dihydro-5H-5l4,6l4-dipyrrolo[1,2-c:2',1'-f][1,3,2]diazaborinine
|
MESO-CF3-BODIPY 2
|
1642327-22-7
|
|
|
2-(biphenyl-4-yl)-4-(4-chlorophenyl)-6-phenyl-1,3,5-triazine
|
2-(1,1'联苯-4-基)-4-(4-氯苯基)-6-苯基-1,3,5-三嗪
|
1642330-72-0
|
C27H18ClN3
|
|
11,12-Dihydro-11-(1,1-dipheny-3-yl)-indolo[2,3-a]carbazole
|
2-([1,1'-联苯] -4-基)-4-苯基-6-(4-(4,4,5,5-四甲基-1,3,2-二氧硼杂环戊烷-2-基)苯基)-1,3,5-三嗪
|
1642330-73-1
|
C33H30BN3O2
|
|
NGABCYSYENPREI-RYUDHWBXSA-N
|
NGABCYSYENPREI-RYUDHWBXSA-N
|
1642330-94-6
|
C15H26O6
|
|
Mono-tert-butyl docosanedioate
|
二十二烷二酸单叔丁酯
|
1642333-05-8
|
C26H50O4
|
|
tert-Butyl 20-bromoicosanoate
|
20-溴二十酸叔丁酯
|
1642333-07-0
|
C24H47BrO2
|
|
1642341-20-5
|
1642341-20-5
|
1642341-20-5
|
C11H12ClN
|
|
Benzenamine, N,N-bis(4-fluorophenyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
|
4-FLUORO-N-(4-FLUOROPHENYL)-N-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)ANILINE
|
1642347-36-1
|
C24H24BF2NO2
|
|
4,7-dibromo-5,6-bis((2-ethylhexyl)oxy)benzo[c][1,2,5]thiadiazole
|
PM241
|
1642535-94-1
|
C22H34Br2N2O2S
|
|
2-bromo-4-chloro-6-fluoronitrobenzene
|
1-溴-5-氯-3-氟-2-硝基苯
|
1642542-05-9
|
C6H2BrClFNO2
|
|
BocNH-PEG12-CH2CH2NH2
|
BocNH-PEG12-CH2CH2NH2
|
1642551-09-4
|
C31H64N2O14
|
|
N-BOC-1H-Indole-4-methanamine,N-(4-fluoro-2-methylphenyl)-2-methyl-
|
N-BOC-1H-INDOLE-4-METHANAMINE,N-(4-FLUORO-2-METHYLPHENYL)-2-METHYL-
|
1642555-01-8
|
C22H25FN2O2
|
|
Oxacillin Sodium Impurity D(EP)
|
苯唑西林钠EP杂质D
|
1642559-63-4
|
C18H21N3O4S
|
|
Cloxacillin Sodium EP Impurity B (Mixture of Diastereomers)
|
氯唑西林EP杂质B
|
1642559-64-5
|
C18H20ClN3O4S
|
|
(4S)-2-(((R)-2-Amino-2-(4-hydroxyphenyl)acetamido)(carboxy)methyl)-5,5-dimethylthiazolidine-4-carboxylic acid, Sodium Salt
|
阿莫西林USP杂质D
|
1642559-71-4
|
C16H21N3O6S.Na
|
|
Carvacrol-β-D-glucuronide
|
Carvacrol-β-D-glucuronide
|
1642562-02-4
|
C16H22O7
|
|
1H-Pyrazolo[3,4-c]pyridine-3-carboxamide, 4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-
|
1H-Pyrazolo[3,4-c]pyridine-3-carboxamide, 4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-
|
1642569-42-3
|
C20H17N5O5
|
|
(S)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
|
(S)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
|
1642571-07-0
|
C22H22N6O
|
|
Ibrutinib Impurity 21
|
Ibrutinib Impurity 21
|
1642571-08-1
|
C27H30N6O3
|
|
Glumetinib
|
谷美替尼
|
1642581-63-2
|
C21H17N9O2S
|
|
1-Isopropyl-4-(4,4,5,5-tetraMethyl-[1,3,2]dioxaborolan-2-yl)-1,2,3,6-tetrahydro-pyridine
|
1-异丙基-4-(4,4,5,5-四甲基-1,3,2-二氧硼杂环戊烷-2-基)-1,2,3,6-四氢吡啶
|
1642583-50-3
|
C14H26BNO2
|
|
ethyl 2-[(1r,4r)-4-[(dimethylcarbamoyl)amino]cyclohexyl]acetate
|
2-[(1R,4R)-4-[(二甲基氨基甲酰基)氨基]环己基]乙酸乙酯
|
1642586-63-7
|
C13H24N2O3
|
|
Pyridine, 3,5-bis(2H-tetrazol-5-yl)-
|
Pyridine, 3,5-bis(2H-tetrazol-5-yl)-
|
1642594-25-9
|
C7H5N9
|
|
4,5-dimethylquinolin-2-ol
|
4,5-二甲基喹啉-2-醇
|
1642600-25-6
|
C11H11NO
|
|
Rivaroxaban Impurity 79
|
利伐沙班杂质79
|
1642601-00-0
|
C38H38N4O12
|
|
(4S)-2-(((R)-2-Amino-2-phenylacetamido)(carboxy)-methyl)-5,5-dimethylthiazolidine-4-carboxylic
|
(4S)-2-(((R)-2-Amino-2-phenylacetamido)(carboxy)-methyl)-5,5-dimethylthiazolidine-4-carboxylic
|
1642629-93-3
|
C16H21N3O5S
|
|
Amoxicillin trihydrate imp. D (EP) as sodium salt:(4S)-2-[[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-carboxymethyl]-5,5-dimethylthiazolidine-4-carboxylic acid sodium salt (penicilloicacids of amo
|
阿莫西林杂质D
|
1642629-94-4
|
C16H21N3O6S
|
|
(4S)-4-Carboxy-5,5-dimethyl-α-[[(5-methyl-3-phenyl-4-isoxazolyl)carbonyl]amino]-2-thiazolidineacetic acid
|
(4S)-4-Carboxy-5,5-dimethyl-α-[[(5-methyl-3-phenyl-4-isoxazolyl)carbonyl]amino]-2-thiazolidineacetic acid
|
1642629-95-5
|
C19H21N3O6S
|
|
Cloxacillin EP Impurity A
|
Cloxacillin EP Impurity A
|
1642629-96-6
|
C19H20ClN3O6S
|
|
(S)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)
|
(S)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)
|
1642630-12-3
|
C22H22N6O
|
|
4-Pyridinebutanenitrile, 2-bromo-
|
4-(2-溴吡啶-4-基)丁腈
|
1642786-45-5
|
C9H9BrN2
|
|
4-(3-Carboxypropyl)-2,2'-bipyridine
|
2,2'-联吡啶-4-(3-羧丙基)
|
1642786-47-7
|
C14H14N2O2
|
|
1642790-57-5
|
1642790-57-5
|
1642790-57-5
|
C25H35F3O5S
|
|
2-Bromo-4-hydroxy-5-nitro-benzoic acid methyl ester
|
|
1642794-97-5
|
C11H12BrNO5
|
|
(DES-PYR1)-LEUPROLIDE
|
(DES-PYR1,DES-GLY10,D-LEU6,PRO-NHET9)-LHRH
|
1642799-35-6
|
C54H79N15O10
|
|
INNYA-2292002
|
杂质多肽INNYA-2292002
|
1642799-36-7
|
C25H48N8O4
|
|
5,6-Bis(octyloxy)-4,7-bis(5-(trimethylstannyl)thiophen-2-yl)benzo[c][1,2,5]thiadiazole
|
5,6-双(辛氧基)-4,7-双[5-(三甲基锡) -2-噻吩基]苯并[C][1,2,5]噻二唑
|
1642803-98-2
|
C36H56N2O2S3Sn2
|
|
1H-Imidazo[4,5-c]pyridin-6-amine, 2-(2-furanyl)-1-methyl-N-(3,4,5-trimethoxyphenyl)-
|
化合物GRK5-IN-2
|
1642839-27-7
|
C20H20N4O4
|
|
6-broMo-5-(trifluoroMethyl)pyridin-3-aMine
|
6-溴-5-(三氟甲基)吡啶-3-胺
|
1642844-33-4
|
C6H4BrF3N2
|
|
4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophene-2-carbonitrile
|
4-(4,4,5,5-四甲基-1,3,2-二氧杂硼烷-2-基)噻吩-2-腈
|
1642844-61-8
|
C11H14BNO2S
|
|
2-(1-Bromonaphthalen-2-yl)-4,6-diphenyl-1,3,5-triazine
|
2-(1-溴萘-2-基)-4,6-二苯基-1,3,5-三嗪
|
1642848-97-2
|
C25H16BrN3
|
|
TPTZ
|
TPTZ
|
1642849-37-3
|
C16H12N6
|
|
Dabigatran iMpurity F
|
达比加群杂质F
|
1642853-67-5
|
C19H20N4O4
|
|
2-Allyloxy-benzaldehyde oxime
|
|
1642857-43-9
|
C10H11NO2
|
|
3-(Naphthalen-2-yloxy)propyl acrylate
|
3-(萘-2-基氧基)丙酯
|
1642857-58-6
|
C16H16O3
|
|
TLR7-IN-1
|
CS-2748
|
1642857-69-9
|
C17H16N6O2
|
|
(11bS)-2,6-bis[3,5-bis(trifluoromethyl)phenyl]-
N,N-bis[(1R)-1-phenylethyl]-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-
4-amine
|
(11BS)-2,6-双[3,5-双(三氟甲基)苯基]-N,N-双[(1R)-1-苯基乙基]-二萘并[2,1-D:1',2'-F][1,3,2]二氧杂膦-4-胺
|
1642864-21-8
|
C52H34F12NO2P
|
|
Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, 2,6-dibromo-N,N-bis[(1S)-1-phenylethyl]-, (11bR)-
|
(11BR)-2,6-二溴-N,N-双((S)-1-苯基乙基)二萘并[2,1-D:1',2'-F][1,3,2]二氧磷杂-4-胺
|
1642864-91-2
|
C36H28Br2NO2P
|
|
(11bR)-2,6-dibromo-N,N-bis((R)-1-phenylethyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine
|
(11BR)-2,6-二溴-N,N-双((R)-1-苯基乙基)二萘并[2,1-D:1',2'-F][1,3,2]二氧磷杂-4-胺
|
1642864-94-5
|
C36H28Br2NO2P
|
|
Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, 2,6-diiodo-N,N-bis[(1R)-1-phenylethyl]-, (11bS)-
|
(11BS)-2,6-二碘-N,N-双((R)-1-苯基乙基)二萘并[2,1-D:1',2'-F][1,3,2]二氧磷杂-4-胺
|
1642865-17-5
|
C36H28I2NO2P
|
|
Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, 2,6-diiodo-N,N-bis[(1S)-1-phenylethyl]-, (11bR)-
|
(11BR)-2,6-二碘-N,N-双((S)-1-苯基乙基)二萘并[2,1-D:1',2'-F][1,3,2]二氧磷杂-4-胺
|
1642865-22-2
|
C36H28I2NO2P
|
|
Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, 2,6-diiodo-N,N-bis[(1R)-1-phenylethyl]-, (11bR)-
|
(11BR)-2,6-二碘-N,N-双((R)-1-苯基乙基)二萘并[2,1-D:1',2'-F][1,3,2]二氧磷杂-4-胺
|
1642865-37-9
|
C36H28I2NO2P
|
|
Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine, 8,9,10,11,12,13,14,15-octahydro-2,6-diphenyl-N,N-bis[(1R)-1-phenylethyl]-, (11bS)-
|
(11BS)-2,6-二苯基-N,N-双((R)-1-苯乙基)-8,9,10,11,12,13,14,15-八氢二萘并[2,1-D:1',2'-F][1,3,2]二氧磷杂环庚-4-胺
|
1642865-72-2
|
C48H46NO2P
|
|
N-Propylsulfuric diamide-sodium
|
丙胺基磺酰胺钠盐
|
1642873-03-7
|
C3H11N2NaO2S
|
|
Macitentan Impurity 11
|
马西替坦杂质11
|
1642873-04-8
|
C12H10BrClN2O2
|
|
tert-butyl 2-oxo-1-oxa-3,7-diazaspiro[4.4]nonane-7-carboxylate
|
叔-丁基 2-氧亚基-1-氧杂-3,7-二氮杂螺[4.4]壬烷-7-甲酸基酯
|
1642899-83-9
|
C11H18N2O4
|
|
4'',5''-Bis(4'-carboxy[1,1'-biphenyl]-4-yl)[1,1':4',1'':2'',1''':4''',1''''-quinquephenyl]-4,4''''-dicarboxylic acid
|
4'',5''-Bis(4'-carboxy[1,1'-biphenyl]-4-yl)[1,1':4',1'':2'',1''':4''',1''''-quinquephenyl]-4,4''''-dicarboxylic acid
|
1643112-46-2
|
C58H38O8
|
|
[1,1'-Biphenyl]-4-carboxylic acid, 4',4''',4''''',4'''''''-(1,2-ethenediylidene)tetrakis[3-amino-
|
[1,1'-Biphenyl]-4-carboxylic acid, 4',4''',4''''',4'''''''-(1,2-ethenediylidene)tetrakis[3-amino-
|
1643112-47-3
|
C54H40N4O8
|
|
H4ftebpe
|
4',4''',4''''',4'''''''-(乙烯-1,1,2,2-四基)四(3-氟-[1,1'-联苯]-4-羧酸)
|
1643112-48-4
|
C54H32F4O8
|
|
4'',4''''',4'''''''',4'''''''''''-(ethene-1,1,2,2-tetrayl)tetrakis(([1,1':4',1''-terphenyl]-4-carboxylic acid))
|
4'',4''''',4'''''''',4'''''''''''-(ethene-1,1,2,2-tetrayl)tetrakis(([1,1':4',1''-terphenyl]-4-carboxylic acid))
|
1643112-50-8
|
C78H52O8
|
|
Tenofovir Impurity 117
|
Tenofovir Impurity 117
|
1643116-22-6
|
C8H11N5O
|
|
(R)-(((1-(6-amino-3H-purin-3-yl)propan-2-yl)oxy)methyl)phosphonic acid
|
替诺福韦酯杂质Q
|
1643116-24-8
|
C9H14N5O4P
|
|
YZ129
|
YZ129
|
1643120-60-8
|
C19H12N2O2
|
|
SAFit1
|
SAFit1
|
1643125-32-9
|
C42H53NO11
|
|
SAfit2
|
1643125-33-0
|
1643125-33-0
|
C46H62N2O10
|
|
GeMcitabine Diphosphate Choline
|
GeMcitabine Diphosphate Choline
|
1643126-46-8
|
C14H24F2N4O10P2
|
|
Febuxostat Impurity 130
|
Febuxostat Impurity 130
|
1643131-93-4
|
C20H25NO5S
|
|
sodium 2-(3-methoxypyridin-2-yl)acetate
|
1643136-45-1
|
1643136-45-1
|
C8H8NNaO3
|
|
Sodium 2-(3-fluoropyridin-2-yl)acetate
|
2-(3-氟吡啶-2-基)乙酸钠
|
1643136-66-6
|
C7H7FNNaO2
|
|
(R)-2-(1-(2-(bis(tert-butoxycarbonyl)amino)-5-bromopyridin-3-yloxy)ethyl)-4-fluorobenzoicacid
|
|
1643141-17-6
|
C24H28BrFN2O7
|
|
2-Chlorofuro[3,2-d]pyrimidine
|
2-氯呋喃并[3,2-D]嘧啶
|
1643142-50-0
|
C6H3ClN2O
|
|
4-broMo-5-fluoro-2-hydrazinylbenzoic acid hydrochloride
|
4-BROMO-5-FLUORO-2-HYDRAZINYLBENZOIC ACID HYDROCHLORIDE
|
1643156-18-6
|
C7H7BrClFN2O2
|
|
5-Bromo-6-fluoro-2,3,4,9-tetrahydro-2-(1-hydroxy-1-methylethyl)-1H-carbazole-8-carboxamide
|
1643156-21-1
|
1643156-21-1
|
C16H18BrFN2O2
|
|
(S)-5-bromo-6-fluoro-2-(2-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-1H-carbazole-8-carboxamide
|
1643156-23-3
|
1643156-23-3
|
C16H18BrFN2O2
|
|
5-Bromo-2-iodo-4-methyl-phenylamine
|
5-Bromo-2-iodo-4-methyl-phenylamine
|
1643156-27-7
|
C7H7BrIN
|
|
2-Amino-4-bromo-5-methylbenzonitrile
|
|
1643156-28-8
|
C8H7BrN2
|
|
2-Amino-4-bromo-5-methyl-benzoic acid
|
2-氨基-4-溴-5-甲基苯甲酸
|
1643156-29-9
|
C8H8BrNO2
|
|
15406-A3
|
|
1643177-29-0
|
C11H12O
|
|
ethyl 5-hydroxy-1a,6b-dihydro-1H-cyclopropa[b]benzofuran-1-carboxylate
|
乙基 5-羟基-1A,6B-二氢-1H-环丙烯并[B]苯并呋喃-1-甲酸基酯
|
1643327-59-6
|
C12H12O4
|
|
5-chloro-N-(4-(5-morpholino-6-oxo-3,6-dihydropyridin-1(2H)-yl)phenyl)pentanamide
|
5-氯-N-(4-(3-吗啉代-2-氧代-5,6-二氢吡啶-1(2H)-基)苯基)戊酰胺
|
1643330-62-4
|
C20H26ClN3O3
|
|
Rivaroxaban Impurity 61
|
利伐沙班杂质56
|
1643354-27-1
|
C32H30N4O8
|
|
Methyl 2,3-dichloroquinoxaline-5-carboxylate
|
Methyl 2,3-dichloroquinoxaline-5-carboxylate
|
1643354-85-1
|
C10H6Cl2N2O2
|
|
Linagliptin Dimer Impurity 6
|
利拉利汀二聚体杂质6
|
1643364-41-3
|
C54H62N16O4
|
|
[1,3-Bis[2,6-bis(i-propyl)phenyl]-2-imidazolidinylidene]difluoromethylsilver(I)
|
1,3-BIS[2,6-BIS(I-PROPYL)PHENYL]-2-IMIDAZOLIDINYLIDENE]DIFLUOROMETHYLSILVER(I)
|
1643366-13-5
|
C28H39AgF2N2
|
|
BMS-986142
|
BMS986142
|
1643368-58-4
|
C32H30F2N4O4
|
|
Dabigatran Etexilate iMpurity
|
达比加群酯杂质
|
1643377-48-3
|
C25H26N8O2
|
|
Ticagrelor Impurity 68
|
Ticagrelor Impurity 68
|
1643378-46-4
|
C23H29FN6O4S
|